The research team led by Professors Young Eun Jang and Jung Bin Park from the Department of Anesthesiology and Pain Medicine ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has opined ...
AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance ...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...
PharmaJet will deliver 2 presentations at the PODD conference on Oct. 27 focusing on current and future applications of their ...
Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...
Biocon Ltd on Thursday said its arm Biocon Biologics Ltd has received an approval from Health Canada for chronic autoimmune ...
Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that Health Canada has granted a Notice of ...
The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics' presence in North America and expands its immunology portfolio ...
News-Medical.Net on MSN
Semaglutide protects the heart beyond weight loss, SELECT trial shows
Semaglutide lowered the risk of major adverse cardiovascular events across all body weight and waist circumference levels in ...
The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback